Liquidia stock price target raised to $47 from $41 at Raymond James

Published 04/11/2025, 11:36
Liquidia stock price target raised to $47 from $41 at Raymond James

Investing.com - Raymond James raised its price target on Liquidia Technologies (NASDAQ:LQDA) to $47.00 from $41.00 on Tuesday, while maintaining a Strong Buy rating following the company’s third-quarter earnings report. This target sits below the analyst high target of $54, according to InvestingPro data, which also shows LQDA trading near its Fair Value based on comprehensive financial analysis.

The pharmaceutical company reported Yutrepia net sales of $51.7 million in its first full quarter of launch, exceeding consensus estimates of $15.5 million by more than three times. This performance helped Liquidia achieve profitability earlier than expected, reaching this milestone in less than two full quarters rather than the previously guided three to four quarters.

Yutrepia sales increased by approximately $45 million quarter-over-quarter, compared to a $14 million increase for the U.S. Tyvaso franchise, indicating Liquidia captured about 75% of revenue growth in the space during the third quarter. This impressive growth has contributed to LQDA’s staggering 343% year-over-year revenue increase and 141% stock price return over the past year, as tracked by InvestingPro.

Raymond James noted that Liquidia now has contracts with the three major pharmacy benefit managers (PBMs), and the removal of new patient blocks is progressing, which should support continued growth.

The firm substantially increased its unadjusted peak sales estimate for Yutrepia to approximately $2 billion from $1.1 billion previously, citing "convincing early launch strength" despite adjusting its model for risks associated with potential trademark case outcomes. While LQDA boasts an impressive 89% gross profit margin, InvestingPro identifies that the company is not yet profitable over the last twelve months. Discover more insights and 10+ additional ProTips in the comprehensive Pro Research Report, available for Liquidia and 1,400+ other US equities.

In other recent news, Liquidia Technologies Inc. reported its third-quarter 2025 earnings, exceeding market expectations with a strong performance. The company announced an earnings per share (EPS) of -$0.04, which was significantly better than the anticipated -$0.41. Revenue also showed a remarkable increase, reaching $54.34 million, far surpassing the projected $18.33 million. These results indicate a substantial boost in the company’s financial performance. Additionally, the earnings announcement was followed by a notable rise in investor optimism. The results are considered a positive development for Liquidia Technologies. These recent updates reflect significant progress in the company’s financial standing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.